Genenta Science Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Pierluigi Paracchi
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 11.8yrs |
| CEO ownership | 12.0% |
| Management average tenure | 4.4yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
We're Keeping An Eye On Genenta Science's (NASDAQ:GNTA) Cash Burn Rate
Jan 26
We're Hopeful That Genenta Science (NASDAQ:GNTA) Will Use Its Cash Wisely
Jul 21We're Not Worried About Genenta Science's (NASDAQ:GNTA) Cash Burn
Dec 10We're Hopeful That Genenta Science (NASDAQ:GNTA) Will Use Its Cash Wisely
Sep 09Gene therapy developer Genenta Science named a buy at Wainwright on tumor approach
Jul 25Is Genenta Science (NASDAQ:GNTA) In A Good Position To Invest In Growth?
Mar 18CEO
Pierluigi Paracchi (52 yo)
Mr. Pierluigi Paracchi, DEc, is Co-Founder of Genenta Science S.p.A., serves as its Chief Executive Officer and was its General Manager and served as its Chairman until November 2020 and was its Vice Chair...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | no data | no data | 11.99% $ 5.5m | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | no data | 7.24% $ 3.3m | |
| CO-Founder & Scientific Advisory Board Member | no data | no data | 3.62% $ 1.7m | |
| Chief Financial Officer | 4.4yrs | no data | 0.12% $ 53.2k | |
| Acting Chief Medical Officer | no data | no data | no data | |
| Director of Program Development | 2.8yrs | no data | 0.16% $ 72.8k | |
| Director of Finance | 4.8yrs | no data | 0% $ 0 |
Experienced Management: GNTA's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 11.8yrs | no data | 11.99% $ 5.5m | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | no data | 7.24% $ 3.3m | |
| CO-Founder & Scientific Advisory Board Member | no data | no data | 3.62% $ 1.7m | |
| Acting Chief Medical Officer | less than a year | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 4.4yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.4yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.4yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.4yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Chairman of the Board of Statutory Auditors | 4.4yrs | no data | no data |
Experienced Board: GNTA's board of directors are considered experienced (4.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/29 21:24 |
| End of Day Share Price | 2025/10/29 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Genenta Science S.p.A. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Pantginis | H.C. Wainwright & Co. |
| Emanuela Branchetti | H.C. Wainwright & Co. |
| Jason McCarthy | Maxim Group |